Effects of Cognitive Correction and Stimulus Control in Chronic Insomnia Patients
Launched by XUANWU HOSPITAL, BEIJING · Oct 23, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to explore how two specific treatments—cognitive correction and stimulus control—can help people with chronic insomnia. Chronic insomnia is a condition where individuals have trouble sleeping regularly, and this study aims to better understand how changing thoughts about sleep and managing sleeping environments can improve sleep quality and behaviors.
To participate in the trial, individuals must be at least 18 years old, have a diagnosis of insomnia, and show specific sleep-related issues on questionnaires. Participants should not have severe physical or mental health problems, and certain sleep disorders or other specific conditions may prevent someone from joining. While the study is not yet recruiting, those who participate can expect guidance on how to improve their sleep habits and cognitive patterns related to sleep. It’s a chance to contribute to research that may help others struggling with insomnia in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Meets the diagnostic criteria for insomnia disorder according to DSM-5;
- • 2. PSQI total score \> 5;
- • 3. Age ≥ 18 years, with at least a junior high school education;
- • 4. Sleep cognitive distortions assessed using the DBAS-16;
- • 5. "Maladaptive Sleep Behavior Questionnaire - 8 items" used to assess "maladaptive sleep behaviors";
- • 6. Willing to participate in the study and sign an informed consent form.
- Exclusion Criteria:
- • 1. Presence of severe physical illness or serious mental disorders, or at risk for suicide;
- • 2. Clinically diagnosed or suspected sleep-related breathing disorders, restless legs syndrome, and circadian rhythm sleep-wake disorders; shift workers;
- • 3. Pregnant or lactating women;
- • 4. Currently undergoing any form of psychological therapy.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported